APELLIS PHARMACEUTICALS INC (APLS)       55.22  -1.51 (-2.66%)

55.22  -1.51 (-2.66%)

US03753U1060 - Common Stock

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
250.6M66.563M
-73.44%		79.413M
19.31%
EBITDA
-287.76M-213.06M
25.96%		-534.898M
-151.06%		-597.19M
-11.65%		N/AN/AN/AN/A
EBIT
-288M
-125.18%		-213.7M
25.80%		-536.277M
-150.95%		-601.973M
-12.25%
Operating Margin
N/A-85.28%-805.67%-758.03%
EPS
-4.86
-108.40%		-4.72
2.88%		-8.93
-89.19%		-6.45
27.79%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS-1.48
34.95%		-1.65
-2.22%
Revenue22.025M
289.82%		25.32M
-58.00%
EBITDA-139.249M-147.226M
EBIT-156.529M
-22.29%		-161.184M
-80.29%

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 -1.75 -1.48 -0.27-17.99% Q2 2022 -1.46 -1.39 -0.07-4.87% Q1 2022 -1.42 -1.35 -0.07-5.49% Q4 2021 -1.61 -1.57 -0.04-2.63% Q3 2021 -2.28 -1.73 -0.55-31.79% Q2 2021 -2.72 -1.72 -1.00-58.19% Q1 2021 -2.32 -1.62 -0.70-43.34% Q4 2020 0.93 -0.77 1.70221.15%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 22.056M 22.025M 31K0.14% Q2 2022 16.322M 17.283M -961K-5.56% Q1 2022 14.381M 12.824M 1.557M12.14% Q4 2021 60.29M 8.96M 51.33M572.88% Q3 2021 5.65M 7.37M -1.72M-23.34% Q2 2021 623K 509.918K 113.082K22.18% Q1 2021 2.318M -2.318M-100.00% Q4 2020 250M 98.008M 151.992M155.08%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPS0% -4.14% 0% -5.88%
Revenue0% -7.35% 0% -1.55%